139 results
DEFA14A
ACST
Acasti Pharma Inc.
6 Sep 24
Additional proxy soliciting materials
4:07pm
.
“FOR” the approval of the 2024 Equity Incentive Plan, as disclosed in the Proxy Statement/Prospectus.
Please vote your shares today. If you need assistance
8-K
EX-10.1
ACST
Acasti Pharma Inc.
16 Aug 24
Departure of Directors or Certain Officers
4:05pm
time to time an option to purchase common shares in the capital of the Company (the “Option”) pursuant to the Company’s equity incentive plan (the “Plan
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
— ACASTI PHARMA INC. 2024 EQUITY INCENTIVE PLAN
F-1
ANNEX G — FORM OF ARTICLES
G-1
ANNEX H — SECTION 372 TO SECTION 388 OF THE QBCA
H-1
ANNEX I — FORM … , and if thought advisable, approve, subject to and conditional upon the approval of the Domestication Resolution, the 2024 Equity Incentive Plan; and
to transact
8-K
dpedmq0hjg 7309b
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
siqzyo3c0uvrifx
8 Jan 24
Departure of Directors or Certain Officers
7:30am
424B3
wqb439
16 Oct 23
Prospectus supplement
4:31pm
8-K
EX-10.1
e5t1i
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
S-8
y3i6uby
25 Aug 23
Registration of securities for employees
5:01pm